(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CARDIOCEL

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CARDIOCEL

ST13

US500000079139776

Classe

5, 10

Pedido

79139776

Registro

4661459

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

64

Atualização mais recente

27/02/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10

Data de depósito

27/09/2013

Data de registro

30/12/2014

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

13/12/2024

Última transação

27/02/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

Burlington, MA, US

Examinador

MARTIN, CHRISTINE C

Localização atual

Historical data usage

Titulares e representantes

Titulares

LeMaitre Vascular, Inc.
Admedus Ltd
Allied Healthcare Group Ltd

Representantes

David J. Dykeman Greenberg Traurig, LLP

Classificação técnica

Classes Nice

Classe 5Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical products and preparations for soft tissue repair; regenerativebiological tissue for grafts and implants; stem cells for medical and veterinary use; vaccines; surgical implants comprising living tissue; biological tissue grafts and cultures for medical purposes in the nature of patches ; biological tissue containing collagen for grafts and implants; biological tissue cultures for medical or veterinary purposes; medical and pharmaceutical preparations for the regeneration of tissue and soft tissue repair; implants comprising living tissue for guided tissue regeneration; veterinary products and preparations for soft tissue repair; materials for dressingsmedical and surgical dressings; material for stopping teeth

Classe 10

Cardiovascular biomaterial patch in the form of a surgical implant made of artificial materials

Publicações

Histórico de despachos e eventos da marca no USPTO.

64 publicações encontradas

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

26/02/2026

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

03/02/2026

INPC

INVALIDATION PROCESSED

03/02/2026

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

13/08/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

13/12/2024

71AG

REGISTERED-SEC.71 ACCEPTED

13/12/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/11/2024

ES71

TEAS SECTION 71 RECEIVED

19/03/2024

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

30/12/2023

RNWL

INTERNATIONAL REGISTRATION RENEWED

12/10/2023

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

20/10/2020

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

20/10/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

20/10/2020

ES75

TEAS SECTION 71 & 15 RECEIVED

11/06/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

24/01/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

24/01/2020

CHLD

CHANGE OF OWNER RECEIVED FROM IB

09/01/2020

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

30/12/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/07/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

28/05/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

26/03/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

26/03/2019

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

05/04/2018

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

16/02/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

29/09/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

30/08/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

30/08/2017

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/06/2015

FICS

FINAL DISPOSITION NOTICE SENT TO IB

15/05/2015

FIMP

FINAL DISPOSITION PROCESSED

15/05/2015

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

30/03/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

30/12/2014

TMBN

TTAB RELEASE CASE TO TRADEMARKS

21/11/2014

OP.T

OPPOSITION TERMINATED NO. 999999

21/11/2014

OP.D

OPPOSITION DISMISSED NO. 999999

21/11/2014

RFNT

REFUSAL PROCESSED BY IB

08/11/2014

OP.I

OPPOSITION INSTITUTED NO. 999999

17/10/2014

OPNS

OPPOSITION NOTICE (IB REFUSAL) SENT TO IB

15/10/2014

OPNC

OPPOSITION NOTICE (IB REFUSAL) CREATED

15/10/2014

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

15/08/2014

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

08/05/2014

PUBO

PUBLISHED FOR OPPOSITION

15/04/2014

GPNX

NOTIFICATION PROCESSED BY IB

11/04/2014

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

26/03/2014

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

26/03/2014

NPUB

NOTICE OF PUBLICATION

26/03/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/03/2014

CNEA

EXAMINERS AMENDMENT MAILED

10/03/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/03/2014

XAEC

EXAMINER'S AMENDMENT ENTERED

10/03/2014

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/03/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/03/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/03/2014

ALIE

ASSIGNED TO LIE

03/03/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

24/02/2014

RFNT

REFUSAL PROCESSED BY IB

12/02/2014

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

22/01/2014

RFRR

REFUSAL PROCESSED BY MPU

22/01/2014

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

16/01/2014

CNRT

NON-FINAL ACTION WRITTEN

15/01/2014

DOCK

ASSIGNED TO EXAMINER

13/01/2014

MAFR

APPLICATION FILING RECEIPT MAILED

17/12/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

13/12/2013

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/12/2013

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CARDIOCEL ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.